Novartis India Ltd

Novartis India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 14 June 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Novartis India Ltd experienced a notable decline today, touching an intraday low of Rs 1360, reflecting a sharp price correction amid broader market weakness and sector underperformance. The stock’s downward trajectory was marked by a 7.16% fall from its previous close, underscoring immediate selling pressure and cautious sentiment among market participants.

Novartis India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, returns, and market standing.

Surging to a new 52-week high of Rs 1588.4 on 1 Jun 2026, Novartis India Ltd has demonstrated remarkable price momentum, outperforming the Sensex by a wide margin over the past year. This milestone caps a 47.29% rally from its 52-week low of Rs 750, underscoring a sustained uptrend fuelled by strong technical signals across multiple timeframes.

Novartis India Ltd has reached a significant milestone by touching an all-time high price of Rs. 1,588.40 on 1 June 2026, marking a remarkable phase in the company’s market performance within the Pharmaceuticals & Biotechnology sector.

Extending its remarkable rally, Novartis India Ltd touched a fresh all-time high of Rs 1,497.35 on 29 May 2026, marking a significant milestone in its multi-year ascent that has outpaced the broader market by a wide margin.

With a decisive break above Rs 1496.85 on 29 Jun 2026, Novartis India Ltd has reached a fresh 52-week high, extending its impressive 39.98% return over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained gains over the last three trading sessions, signalling robust price action in the pharmaceuticals sector.

Surging to a fresh 52-week high of Rs 1462.5 on 27 Jun 2026, Novartis India Ltd has demonstrated robust price momentum, outperforming its sector and the broader market with a 34.09% gain over the past year against the Sensex’s decline of 6.70%.

Novartis India Ltd has reached a significant milestone by touching its all-time high price of ₹1,458 on 27 May 2026, marking a remarkable phase in the company’s market journey. This achievement reflects sustained strength in the pharmaceuticals and biotechnology sector, with the stock outperforming key benchmarks and demonstrating robust technical and financial metrics.

Surging to an intraday peak of Rs 1430 on 26 Jun 2026, Novartis India Ltd has marked a significant milestone by reaching a fresh 52-week high. This advance comes amid a backdrop of strong technical momentum, with the stock outperforming its sector by 5.22% on the day and trading comfortably above all major moving averages.

Novartis India Ltd has reached a significant milestone by touching its all-time high price of Rs 1,425.00 on 26 May 2026, reflecting a robust performance in the Pharmaceuticals & Biotechnology sector and marking a notable achievement for the small-cap company.

With a decisive surge to Rs 1424.9 on 25 Jun 2026, Novartis India Ltd has reached a fresh 52-week high, marking a remarkable 45.9% gain over the past year. This milestone comes amid a sustained rally that has seen the stock outperform its sector and the broader market, driven predominantly by a strong alignment of technical indicators across multiple timeframes.

Novartis India Ltd has reached a significant milestone by touching its all-time high price of Rs 1,422.25 on 25 May 2026, reflecting robust performance and sustained bullish momentum in the Pharmaceuticals & Biotechnology sector.

Novartis India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 May 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock's current position as of 23 May 2026, providing investors with an up-to-date view of the company’s performance and prospects.

Surging to an intraday peak of Rs 1377 on 22 Jun 2026, Novartis India Ltd has marked a significant milestone by reaching a fresh 52-week high. This rally, underpinned by a 15.42% gain over the past four trading sessions, highlights the stock’s robust momentum amid a broadly positive market backdrop.

Extending its winning streak to four consecutive sessions, Novartis India Ltd surged to a fresh all-time high of Rs 1,370.2 on 22 May 2026, outpacing the broader Sensex which gained a modest 0.48% that day. The stock’s remarkable 16.07% return over this short span highlights a strong upward momentum that has captured market attention.

Novartis India Ltd has reached a significant milestone by touching its all-time high price of Rs.1,345 on 21 May 2026, marking a remarkable phase in the company’s market performance within the Pharmaceuticals & Biotechnology sector.